22 reports

  • 5.1 Global Ophthalmic Diagnostics & Monitoring Devices Market and
  • 6. Global Ophthalmic Diagnostics & Monitoring Devices Market and Forecast (2012 - 2026)

Others GLOBAL OPHTHALMIC DEVICES MARKET - REGIONAL ANALYSIS ##.

  • Eye Disease
  • Eyewear
  • Medical Device
  • Ophthalmology
  • World
  • 4.1 Global Ophthalmic Diagnostics & Monitoring Devices Market and
  • GLOBAL - OPHTHALMIC DIAGNOSTICS & MONITORING DEVICES MARKET (MILLION US$), 2012 - 2018

Others GLOBAL OPHTHALMIC DEVICES MARKET - REGIONAL ANALYSIS ##.

  • Eye Disease
  • Eyewear
  • Medical Device
  • Ophthalmology
  • World
  • The disease is managed using regular cardiac, pulmonary and ophthalmic monitoring, as well as surgical interventions, including

REFERENCES ##.

  • Pathology
  • Northern Europe
  • Western Europe
  • Clinical Trial profile. 7 Trial Title
  • 5. All the trials included are unique trials.

The prominent featur es of this report are - ##.

  • Clinical Trial
  • Drug Development
  • Ophthalmology
  • Therapy
  • Novartis AG
  • 5. All the trials included are unique trials.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd Chengdu Kanghong Pharmaceuticals Group Co Ltd ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## atropine alone or in combination has the highest number of myopia ongoing clinical trials.

  • Clinic
  • Clinical Trial
  • Ophthalmology
  • Therapy
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd Regeneron ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pharmaceuticals Inc ## ## ## ## ## ## ## ## IVERIC bio Inc ## ## ## ## ## ## ## ## Pfizer Inc Novelion Therapeutics Inc Chengdu Kanghong Pharmaceuticals Group Co Ltd ## ## ## ## ##

  • Clinical Trial
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • Clinical Trial Profile Snapshots
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Development
  • Endocrine Disease
  • Monoclonal Antibody
  • Therapy
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • 5. All the trials included are unique trials.

Santen licensed the development rights to DE-## in the ophthalmic field from TRACON in 2014.

  • Clinical Trial
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • GLOBAL OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2017-2025 ($ MILLION)
  • TABLE 9 GLOBAL OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2017-2025 ($ MILLION)

Global Ophthalmic Drugs & Devices Market Forecast 2017-2025 ## RESEARCH SCOPE ##. ## STUDY GOALS ##. ## SCOPE OF MARKET STUDY ##. ## WHO WILL FIND THIS REPORT USEFUL?

  • Ophthalmic Solution
  • OTC
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Eye Disease
  • Ophthalmology
  • Therapy
  • World
  • Novartis AG
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Invest Ophthalmol Vis Sci. 2018 Jun ##.

  • Clinical Trial
  • Eye Disease
  • Health Services
  • Monoclonal Antibody
  • Ophthalmology
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • APAC OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2017-2025 ($ MILLION)
  • TABLE 9 APAC OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2017-2025 ($ MILLION)

Asia-Pacific Ophthalmic Drugs & Devices Market Forecast 2017-2025 ## RESEARCH SCOPE ##. ## STUDY GOALS ##. ## SCOPE OF MARKET STUDY ##. ## WHO WILL FIND THIS REPORT USEFUL?

  • OTC
  • APAC
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd Bayer AG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Regeneron Pharmaceuticals Inc Clearside BioMedical Inc Valeant Pharmaceuticals International Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Clinical Trial
  • Monoclonal Antibody
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • SPAIN HEALTHCARE PACKAGING MARKET , 2018 - 2028 ($ BN)
  • 4.7 ITALY HEALTHCARE PACKAGING MARKET AND FORECAST,

Products / Services ## ## ##. ##. ##.

  • Healthcare
  • Packaging
  • United States
  • DuPont
  • Unither Pharmaceuticals, Inc.
  • 5. All the trials included are unique trials.

ASCRS is a symposium & congress being held jointly with the American Society of Ophthalmic Administrators (ASOA) May ##-##, 2017.

  • Clinical Trial
  • Endocrine Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Therapy
  • 10.4 OPHTHALMIC DIAGNOSTIC & MONITORING DEVICES
  • GLOBAL OPHTHALMIC DIAGNOSTIC AND MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)

The ophthalmic diagnostic and monitoring devices market is witnessing rapid technological changes.

  • Medical Device
  • North America
  • United States
  • World
  • Market Size
  • PARTNERSHIP - DEAL REPORTS

Freedom Meditech will use the grant funding for non-invasive ophthalmic glucose monitoring device.

  • United States
  • Corporate Finance
  • Freedom Meditech, Inc.